GCM
Glenview Capital Management Portfolio holdings
AUM
$3.52B
This Quarter Return
+10.06%
1 Year Return
+13.71%
3 Year Return
+64.03%
5 Year Return
+172.03%
10 Year Return
+274.64%
AUM
$3.19B
AUM Growth
+$3.19B
(-12%)
Cap. Flow
-$736M
Cap. Flow
% of AUM
-23.11%
Top 10 Holdings %
Top 10 Hldgs %
67.11%
Holding
50
New
7
Increased
9
Reduced
27
Closed
5
Top Buys
| 1 |
Myriad Genetics
MYGN
|
$12.4M |
| 2 |
Medtronic
MDT
|
$11.8M |
| 3 |
Amgen
AMGN
|
$11.5M |
| 4 |
Microsoft
MSFT
|
$11.3M |
| 5 |
Healthpeak Properties
DOC
|
$11M |
Top Sells
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
$87.5M |
| 2 |
PARA
Paramount Global Class B
PARA
|
$64.9M |
| 3 |
HCA Healthcare
HCA
|
$64.7M |
| 4 |
DaVita
DVA
|
$50.9M |
| 5 |
FMC
FMC
|
$47.9M |
Sector Composition
| 1 | Healthcare | 73.97% |
| 2 | Technology | 9.8% |
| 3 | Consumer Discretionary | 6% |
| 4 | Materials | 4.64% |
| 5 | Communication Services | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tenet Healthcare
THC
$16.3B
| $484M | 15.2% | 19,761,353 | – | – |
|
2
Takeda Pharmaceutical
TAK
$47.3B
| $300M | 9.4% | 16,788,589 +593,279 | +4% | +$10.6M |
|
3
Bausch Health
BHC
$2.74B
| $232M | 7.3% | 14,957,708 -686,420 | -4% | -$10.7M |
|
4
Cigna
CI
$80.3B
| $222M | 6.97% | 1,310,027 +8,277 | +0.6% | +$1.4M |
|
|
5
HCA Healthcare
HCA
$94.5B
| $204M | 6.41% | 1,638,515 -518,694 | -24% | -$64.7M |
|
6
McKesson
MCK
$85.4B
| $189M | 5.92% | 1,267,259 +48,555 | +4% | +$7.23M |
|
7
DXC Technology
DXC
$2.59B
| $182M | 5.73% | 10,218,215 -1,769,815 | -15% | -$31.6M |
|
8
Labcorp
LH
$23.1B
| $131M | 4.13% | 698,442 -35,602 | -5% | -$6.7M |
|
9
Hologic
HOLX
$14.9B
| $96.4M | 3.03% | 1,450,171 -485,564 | -25% | -$32.3M |
|
|
PARA
10
DELISTED
Paramount Global Class B
PARA
| $96.3M | 3.02% | 3,439,825 -2,316,959 | -40% | -$64.9M |
|
|
MTOR
11
DELISTED
MERITOR, Inc.
MTOR
| $81.1M | 2.54% | 3,871,291 -1,580,189 | -29% | -$33.1M |
|
|
NUAN
12
DELISTED
Nuance Communications, Inc.
NUAN
| $79.9M | 2.51% | 2,406,267 -2,635,864 | -52% | -$87.5M |
|
13
Cencora
COR
$56.5B
| $79.4M | 2.49% | 819,674 -135,485 | -14% | -$13.1M |
|
|
14
FMC
FMC
$4.88B
| $73.6M | 2.31% | 694,509 -452,610 | -39% | -$47.9M |
|
15
IQVIA
IQV
$32.4B
| $66M | 2.07% | 418,985 -132,273 | -24% | -$20.9M |
|
16
Universal Health Services
UHS
$11.6B
| $61.6M | 1.93% | 575,634 -102,518 | -15% | -$11M |
|
17
Corteva
CTVA
$50.4B
| $48.1M | 1.51% | 1,670,774 -846,966 | -34% | -$24.4M |
|
18
Marriott International Class A Common Stock
MAR
$72.7B
| $40.5M | 1.27% | 437,717 -284,172 | -39% | -$26.3M |
|
19
Boston Scientific
BSX
$156B
| $39.9M | 1.25% | 1,045,052 -1,067,949 | -51% | -$40.8M |
|
20
Molina Healthcare
MOH
$9.8B
| $38.1M | 1.2% | 208,374 -123,645 | -37% | -$22.6M |
|
|
21
Myriad Genetics
MYGN
$593M
| $36M | 1.13% | 2,757,993 +947,266 | +52% | +$12.4M |
|
22
Avis
CAR
$5.57B
| $34.8M | 1.09% | 1,321,354 -954,055 | -42% | -$25.1M |
|
23
Humana
HUM
$36.5B
| $34.4M | 1.08% | 83,089 -88,243 | -52% | -$36.5M |
|
24
Brookdale Senior Living
BKD
$1.83B
| $32M | 1% | 12,586,554 -750,000 | -6% | -$1.91M |
|
25
Expedia Group
EXPE
$26.6B
| $31.7M | 0.99% | 345,433 +90,384 | +35% | +$8.29M |
|